1. Home
  2. NKE vs REGN Comparison

NKE vs REGN Comparison

Compare NKE & REGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nike Inc.

NKE

Nike Inc.

HOLD

Current Price

$54.02

Market Cap

94.6B

ML Signal

HOLD

Logo Regeneron Pharmaceuticals Inc.

REGN

Regeneron Pharmaceuticals Inc.

HOLD

Current Price

$746.39

Market Cap

79.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKE
REGN
Founded
1964
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
94.6B
79.4B
IPO Year
1995
1995

Fundamental Metrics

Financial Performance
Metric
NKE
REGN
Price
$54.02
$746.39
Analyst Decision
Buy
Buy
Analyst Count
26
24
Target Price
$76.83
$819.54
AVG Volume (30 Days)
13.0M
559.3K
Earning Date
03-19-2026
01-01-0001
Dividend Yield
3.03%
0.50%
EPS Growth
N/A
8.19
EPS
1.03
41.48
Revenue
$46,309,000,000.00
$5,872,227,000.00
Revenue This Year
$1.76
$11.69
Revenue Next Year
$3.90
$10.06
P/E Ratio
$52.51
$17.98
Revenue Growth
N/A
20.82
52 Week Low
$52.28
$476.49
52 Week High
$80.17
$821.11

Technical Indicators

Market Signals
Indicator
NKE
REGN
Relative Strength Index (RSI) 25.10 42.37
Support Level N/A $740.39
Resistance Level $64.21 $788.69
Average True Range (ATR) 1.33 21.98
MACD -0.77 -4.12
Stochastic Oscillator 2.61 6.97

Price Performance

Historical Comparison
NKE
REGN

About NKE Nike Inc.

Nike is the largest athletic footwear and apparel brand in the world. Footwear generates about two-thirds of its sales. Key performance footwear categories include basketball, running, and football (soccer). Its brands include Nike, Jordan (premium athletic footwear and clothing), NikeSkims (women's athleisure), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores (including about 5,500 in China), and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.

About REGN Regeneron Pharmaceuticals Inc.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has early-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).

Share on Social Networks: